Latest News & Features
Refine Search
Americas
Nichi-Iko Pharmaceutical, a Tokyo-based drugs company, will acquire Illinois-based Sagent Pharmaceuticals for $736 million in cash. 13 July 2016
Americas
An en banc US Court of Appeals for the Federal Circuit said yesterday that two patents owned by The Medicines Company are valid in a case setting the rules for ‘on-sale’ product-by process patents. 12 July 2016
Americas
Merck Sharp & Dohme has filed a lawsuit against Genentech asking the US District Court for the Central District of California to re-evaluate a patent belonging to Genentech. 11 July 2016
Americas
The US Food and Drug Administration has said that an Amgen biosimilar is indeed “highly similar” to AbbVie’s drug Humira in a document released for the advisory committee panel meeting due to be held tomorrow. 11 July 2016
Asia
Healthcare provider Zydus Cadila has signed a sub-licensing agreement with the Medicines Patent Pool (MPP) centring on the generic production of Daklinza (daclatasvir). 8 July 2016
Big Pharma
The Court of Justice of the European Union has said the beneficiary of a patent licence must pay the agreed royalty rate even if it does not infringe the patented technology. 7 July 2016
Asia-Pacific
Legislative developments surrounding supplementary protection certificates in the EU are moving fast, and may be catching on as far afield as Australia. Gareth Morgan of Olswang explains more. 7 July 2016
Americas
Law firm Jones Day has hired John Wehrli as a partner in the firm’s intellectual property practice in San Diego. 7 July 2016
Big Pharma
Following the UK’s vote to leave the EU, it is business as usual for life sciences companies working with intellectual property, at least for now, says Claire Phipps-Jones of Bristows. 7 July 2016
Americas
Run Them Sweet, a US medical diagnostic company, has filed a class-action lawsuit alleging it was overcharged for foreign patent renewal fees by IP management company CPA Global. 6 July 2016